13F
← All fund report cards

Hood River Capital Management LLC

13F equity value
$10.0B
Positions
167
Top 10 concentration
28.5%
Quarters / total new picks
32 / 509
13F equity value over time
$0M$5B$10B2017201820192020202120222023202420252026

"13F equity value" = market value of this filer's US-listed long equity positions only. It excludes cash, bonds, non-US and short positions, so it understates a fund's true assets under management — often by a lot.

Not significant Verdict

13F holdings are disclosed ~45 days after quarter-end, and they never reveal when within the quarter a fund actually bought. So any 13F-based summary is structurally late and blurred — this applies to every fund, including this one.

We backtested copying it anyway. Buying this fund's new positions the day each filing went public, over 32 quarters, returned +3.7% per quarter — versus +2.7% per quarter from simply owning every 13F stock. It beat that baseline in only 53.1% of quarters (excess t = 1.22, not statistically significant). Its filings tell you what it bought — not what you should buy.

Avg 2Q excess
+2.9%
t-stat
1.22
Quarterly win rate
53%
Annualized excess
+2.5%
$1 → follow vs universe
$2.50 vs $2.09
Cumulative return: $1 invested in new picks vs universe
1.00 20180331: universe 1.04120180630: universe 0.95920180930: universe 1.00320181231: universe 0.99220190331: universe 0.97520190630: universe 1.04820190930: universe 1.12720191231: universe 0.90920200331: universe 1.09620200630: universe 1.21120200930: universe 1.48520201231: universe 1.55320210331: universe 1.56620210630: universe 1.69220210930: universe 1.51920211231: universe 1.29220220331: universe 1.38720220630: universe 1.28520220930: universe 1.38120221231: universe 1.28220230331: universe 1.35120230630: universe 1.30320230930: universe 1.47920231231: universe 1.54520240331: universe 1.58020240630: universe 1.72320240930: universe 1.70820241231: universe 1.59420250331: universe 1.73820250630: universe 1.79320250930: universe 2.01620251231: universe 2.085 20180331: follow 1.01220180630: follow 0.90720180930: follow 1.07420181231: follow 1.06820190331: follow 1.00520190630: follow 0.98020190930: follow 1.05920191231: follow 0.91020200331: follow 1.06920200630: follow 1.22820200930: follow 1.69220201231: follow 1.77720210331: follow 1.78620210630: follow 2.07720210930: follow 1.77820211231: follow 1.78320220331: follow 1.92320220630: follow 1.78420220930: follow 1.69220221231: follow 1.43820230331: follow 1.34220230630: follow 1.25320230930: follow 1.50020231231: follow 1.56020240331: follow 1.64820240630: follow 1.99120240930: follow 1.91120241231: follow 1.56220250331: follow 1.60720250630: follow 1.69220250930: follow 2.08920251231: follow 2.500 0.83 1.77 2.70 20182019202020212022202320242025 Follow Universe

Quarterly compounding, invested quarters only · entry 47 days after quarter-end (when 13F data becomes public)

Listed as facts. See the verdict above before treating this as signal.

Top 20 holdings of 167 · 2026 Q1

Ticker Value Weight QoQ
APLD $548M
5.5%
ADD
MTZ $417M
4.2%
TRIM
FIX $344M
3.5%
HOLD
DOCN $299M
3.0%
ADD
XPO $226M
2.3%
HOLD
BE $214M
2.1%
HOLD
FCFS $213M
2.1%
HOLD
DAVE $199M
2.0%
ADD
LITE $194M
1.9%
TRIM
KTOS $191M
1.9%
HOLD
SMTC $176M
1.8%
ADD
BW $170M
1.7%
ADD
KRYS $160M
1.6%
HOLD
QXO $158M
1.6%
HOLD
KNX $154M
1.5%
ADD
MDGL $131M
1.3%
HOLD
GH $121M
1.2%
ADD
CUBI $120M
1.2%
HOLD
LSCC $120M
1.2%
ADD
PRAX $116M
1.2%
ADD

QoQ vs previous quarter's share count · NEW = new position · ADD/TRIM = ±2% shares · HOLD = unchanged.

Listed as facts. See the verdict above before treating this as signal.

New positions in 2026 Q1

Method & Limitations

Method: a "new position" = held this quarter, absent last quarter (options excluded; stocks with <50 prior holders excluded to filter spin-off artifacts). Entry 47 days after quarter-end — the first day the public could act on the filing. Benchmark = equal-weighted universe of all 13F-held stocks. Limitations: quarterly snapshots can't see intra-quarter trades; survivorship bias — funds that shut down are absent, which flatters the sample. Statistics, not advice.